GlassScriptPhysician profile
Ghadeer Alami
NPI 1720338684
$10,511.17
in general payments reported to CMS, 2019-2025
14 companies · $449 in 2025
The $449 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,765 · 2020: $186 · 2021: $2,430 · 2022: $836 · 2023: $1,728 · 2024: $1,117 · 2025: $449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,686 · Travel and Lodging: $1,608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,686.06 |
| Travel and Lodging | $1,607.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $4,152.74 | 2019-2024 | Distal Extremities Implants Trauma Ankle Fracture, Arthrex |
| Stryker Corporation | $3,994.42 | 2019-2025 | Ortholoc 3di, Augment Injectable, Hoffmann |
| Liberty Surgical INC. | $1,126.73 | 2019-2021 | |
| Eclipse Technology Solutions INC. | $777.14 | 2023-2025 | |
| Acumed LLC | $240.07 | 2022-2025 | Acumed, Acumed |
| Zimmer Biomet Holdings, INC. | $73.74 | 2022 | |
| Misonix INC | $38.74 | 2019-2020 | |
| Smith+Nephew, INC. | $29.54 | 2020 | |
| Treace Medical Concepts, INC. | $18.60 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $16.43 | 2024 | Zilretta, Iovera, Exparel |
| Osteomed LLC | $12.97 | 2020 | |
| Bioventus LLC | $12.67 | 2019 | |
| Tactile Systems Technology INC | $12.39 | 2020 | |
| Orthofix Medical, INC. | $4.99 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ghadeer Alami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.